ANTA BIOTECHNOLOGIES CORPORATION — National Aeronautics and Space Administration SBIR: 2025-II
ANTA BIOTECHNOLOGIES CORPORATION — SBIR award from National Aeronautics and Space Administration.
SBIR award competitive context
- Public SBIR obligation from National Aeronautics and Space Administration to ANTA BIOTECHNOLOGIES CORPORATION. Use agency + tech-domain links below to map the broader competitive field.
- Obligated amount $1,275,000 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Space & Satellite, Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
ANTA Biotechnologies Corporation received a $1,275,000 NASA SBIR Phase II award. The funding supports their biotechnology development project.
- Amount
- $1,275,000
- Agency
- National Aeronautics and Space Administration · National Aeronautics and Space Administration
- Program / Phase
- SBIR
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- CA
- Period
- 2026-10-09 → 2028-10-08
Technology domains
Description
SBIR 2025-II